© 2021 All rights reserved, Applied Cannabis Research
The CACOS Study is an observational study being run through the CA Clinics network.
Please find the CA clinics referral form here.
This study has been approved by Bellberry Human Research Ethics Committee.
The CMOS Study is an observational study that will be run in collaboration with GP’s and specialists around Australia. This study aims to recruit 20,000 Australian patients undergoing treatment with medicinal cannabis.
The CMOS Study will benefit participating clinicians, and their patients, by providing insight into medicinal cannabis prescribing and treatment practices from clinics around Australia participating in CMOS. Insights will be provided in the form of de-identified aggregated data reports including information on product dosing/categories being prescribed, patient reported outcomes (PROs) and adverse events reported by study participants, to be released to participating clinics on a quarterly basis.
This data will provide a useful resource for clinicians who may be prescribing medicinal cannabis products and wish to gain better insight into the current Australian prescribing landscape.
The CMOS study is planning to launch in Q3 2020. To register interest in becoming a participating doctor/clinic please see here.
© 2021 All rights reserved, Applied Cannabis Research